Melih Tütüncü

2.5k total citations · 1 hit paper
54 papers, 1.0k citations indexed

About

Melih Tütüncü is a scholar working on Neurology, Pathology and Forensic Medicine and Rheumatology. According to data from OpenAlex, Melih Tütüncü has authored 54 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Neurology, 23 papers in Pathology and Forensic Medicine and 12 papers in Rheumatology. Recurrent topics in Melih Tütüncü's work include Multiple Sclerosis Research Studies (20 papers), Peripheral Neuropathies and Disorders (15 papers) and Myasthenia Gravis and Thymoma (6 papers). Melih Tütüncü is often cited by papers focused on Multiple Sclerosis Research Studies (20 papers), Peripheral Neuropathies and Disorders (15 papers) and Myasthenia Gravis and Thymoma (6 papers). Melih Tütüncü collaborates with scholars based in Türkiye, United States and Antigua and Barbuda. Melih Tütüncü's co-authors include Aksel Sıva, Ayşegül Gündüz, Hülya Apaydın, Görkem Serbes, Hünkar Can Tunç, C. Okan Sakar, M. Erdem Isenkul, Betül Erdoğdu Şakar, Hatice Nizam Ozogur and Tarkan Aydın and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Melih Tütüncü

43 papers receiving 1.0k citations

Hit Papers

A comparative analysis of speech signal processing algori... 2018 2026 2020 2023 2018 100 200 300

Peers

Melih Tütüncü
Snehashis Roy United States
Mohit Neema United States
Marc Silverman United States
Raju Yerra Australia
Mona K. Garvin United States
Ferrán Prados United Kingdom
John Grigg Australia
Melih Tütüncü
Citations per year, relative to Melih Tütüncü Melih Tütüncü (= 1×) peers Xinghu Zhang

Countries citing papers authored by Melih Tütüncü

Since Specialization
Citations

This map shows the geographic impact of Melih Tütüncü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melih Tütüncü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melih Tütüncü more than expected).

Fields of papers citing papers by Melih Tütüncü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melih Tütüncü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melih Tütüncü. The network helps show where Melih Tütüncü may publish in the future.

Co-authorship network of co-authors of Melih Tütüncü

This figure shows the co-authorship network connecting the top 25 collaborators of Melih Tütüncü. A scholar is included among the top collaborators of Melih Tütüncü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melih Tütüncü. Melih Tütüncü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tütüncü, Melih, Serkan Demir, Tuncay Gündüz, et al.. (2024). Exploring the experience of multiple sclerosis patients in Turkey: Insights from a national survey. Neurology Asia. 29(3). 749–761.
3.
Saltık, Sema, Cengiz Yalçınkaya, Melih Tütüncü, et al.. (2023). Ocrelizumab in pediatric multiple sclerosis. European Journal of Paediatric Neurology. 43. 1–5. 17 indexed citations
4.
Şen, Sedat, Murat Terzi, Serkan Özakbaş, et al.. (2023). Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatment. Multiple Sclerosis and Related Disorders. 79. 104949–104949. 4 indexed citations
5.
Uygunoğlu, Uğur, et al.. (2022). Analysis of determinants of treatment change in adult paediatric-onset MS patients. Multiple Sclerosis and Related Disorders. 69. 104463–104463. 1 indexed citations
6.
Tütüncü, Melih, et al.. (2022). Prevalence of clinical manifestations and neuroimaging features in cerebral small vessel disease. Clinical Neurology and Neurosurgery. 217. 107244–107244. 3 indexed citations
7.
Demir, Serkan, Melih Tütüncü, Haluk Gümüş, et al.. (2021). A comprehensive assessment of patient experience and disease-related awareness in multiple sclerosis: A questionnaire-based nation-wide survey in Turkey. Multiple Sclerosis and Related Disorders. 52. 103005–103005. 2 indexed citations
8.
Ülgen, Ege, Uğur Uygunoğlu, Melih Tütüncü, et al.. (2021). Investigation of multiple sclerosis-related pathways through the integration of genomic and proteomic data. PeerJ. 9. e11922–e11922. 1 indexed citations
9.
Bayrak, Ayşe Oytun, Kayıhan Uluç, Necdet Karlı, et al.. (2020). Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP): A Database Analysis (3987). Neurology. 94(15_supplement). 1 indexed citations
10.
Tunç, Hünkar Can, C. Okan Sakar, Hülya Apaydın, et al.. (2020). Estimation of Parkinson’s disease severity using speech features and extreme gradient boosting. Medical & Biological Engineering & Computing. 58(11). 2757–2773. 36 indexed citations
11.
Durmuş, Hacer, Fikret Aysal, Behzat Özkan, et al.. (2020). CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS. Frontiers in Immunology. 11. 809–809. 40 indexed citations
12.
Özdoğan, Huri, Serdal Uğurlu, Uğur Uygunoğlu, et al.. (2020). The efficacy of anti- IL-1 treatment in three patients with coexisting familial Mediterranean fever and multiple sclerosis. Multiple Sclerosis and Related Disorders. 45. 102332–102332. 12 indexed citations
13.
Bozbay, Süha, Yalım Dikmen, Haluk Sayman, et al.. (2019). Co-existence of Multiple Sclerosis and Anti-NMDA Receptor Encephalitis: What We Can Learn From It? (P2.2-091). Neurology. 92(15_supplement).
14.
Sıva, Aksel, Sinem Nihal Esatoğlu, Uğur Uygunoğlu, et al.. (2018). Could neurological involvement in Behçet’s Disease occur atypically? (P5.410). Neurology. 90(15_supplement). 1 indexed citations
15.
Gündüz, Ayşegül, Melih Tütüncü, Burcu Zeydan, et al.. (2017). Electrophysiological Investigations in Orthostatic Myoclonus: Preliminary Findings. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 45(1). 100–103. 5 indexed citations
16.
Uygunoğlu, Uğur, Melih Tütüncü, Ayşe Altıntaş, Sabahattin Saip, & Aksel Sıva. (2017). Factors Predictive of Severe Multiple Sclerosis Disease Reactivation After Fingolimod Cessation. The Neurologist. 23(1). 12–16. 22 indexed citations
17.
Sıva, Aksel, Uğur Uygunoğlu, Melih Tütüncü, Ayşe Altıntaş, & Sabahattin Saip. (2016). Rebound of Disease Activity after Fingolimod Discontinuation: Report of Six Cases (P2.081). Neurology. 86(16_supplement). 1 indexed citations
18.
Sıva, Aksel, Melih Tütüncü, Orhun H. Kantarci, et al.. (2015). Are individuals with Radiologically Isolated Syndrome have a different clinical outcome once they convert to Clinically Isolated Syndrome? (P5.193). Neurology. 84(14_supplement).
19.
Uludüz, Derya, et al.. (2014). Auditory Evoked Blink Reflex in Peripheral Facial Paresis. Journal of Clinical Neurophysiology. 32(1). 34–38. 1 indexed citations
20.
Gündüz, Ayşegül, et al.. (2013). Fasiyal sinir hastalığı prototipinde posteriyor auriküler kas yanıtının özelliklerinin anlaşılması. The Turkish Journal of Ear Nose and Throat. 23(3). 173–178.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026